科研之友
微信
新浪微博
Facebook
分享链接
摘要
Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in the development of autoimmune diseases, and anti-TNF-alpha agents are used in the treatment of this group of diseases. However, some adverse events such as various autoimmune diseases can occur with use of these agents. In this report, we present a female case who was diagnosed as bullous pemphigoid while receiving adalimumab for rheumatoid arthritis. (Turk J Rheumatol 2010; 25: 214-6)
- 出版日期2010
